You are here

obesity

Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval

BioSpace

Mon, 07/22/24 - 06:50 pm

Innovent Biologics

NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers

Yahoo/Raleigh News & Observer

Mon, 07/22/24 - 06:48 pm

5 startups looking to compete in the obesity space

BioSpace

Mon, 07/22/24 - 12:03 pm

ProFound Therapeutics

EraCal Therapeutics

Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.

Motley Fool

Sun, 07/21/24 - 11:02 pm

‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO

Fierce Biotech

Thu, 07/18/24 - 11:13 pm

Roche reports positive data from Phase I obesity treatment trial

Clinical Trials Arena

Wed, 07/17/24 - 12:18 pm

clinical trials

Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts

Fierce Pharma

Fri, 07/12/24 - 11:33 am

Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering

Fierce Biotech

Fri, 07/12/24 - 11:14 am

Viking Therapeutics

Terns Pharmaceuticals

Vivani to start in-human trial for GLP-1 implant for treating obesity

Clinical Trials Arena

Fri, 07/12/24 - 11:08 am

clinical trials

Weight-loss drugs could become a test case for AI

Axios

Tue, 07/9/24 - 09:24 pm

artificial intelligence

GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study

BioSpace

Mon, 07/8/24 - 11:49 am

Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity

Clinical Trials Arena

Tue, 07/2/24 - 11:19 am

Boehringer Ingelheim

clinical trials

India panel urges drug regulator to approve Lilly's obesity drug Mounjaro

Reuters

Mon, 07/1/24 - 09:52 pm

House committee backs some Medicare cover for obesity drugs

Pharmaphorum

Fri, 06/28/24 - 11:13 am

Zealand Pharma brings in $1B to drive development of obesity drugs

First Word Pharma

Wed, 06/26/24 - 10:04 am

Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?

Motley Fool

Tue, 06/25/24 - 11:17 am

ProFound Therapeutics

Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass

BioSpace

Mon, 06/24/24 - 10:18 pm

clinical trials

Obesity drug from Zealand shows potential in early trial

BioPharma Dive

Thu, 06/20/24 - 05:57 pm

clinical trials

Sanders hopes pressure will force down Ozempic price

Axios

Thu, 06/20/24 - 11:23 am

Could Structure Therapeutics Become the Next Novo Nordisk?

Motley Fool

Mon, 06/17/24 - 11:38 am

Structure Therapeutics

Pages